Profiling of oxidative stress in patients with inborn errors of metabolism

Molecular Genetics and Metabolism

Volumn 98, Issue 1-2, 2009, Pages 173-180

  Mc Guire, Peter J ^a   Parikh, Aditya ^a   Diaz, George A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cobalamin disorders; Free radicals; Homocystinuria; Inborn errors of metabolism; Maple syrup urine disease; Ornithine transcarbamylase deficiency; Oxidative stress; Propionic acidemia; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

COBALAMIN; FREE RADICAL; ISOPROSTANE DERIVATIVE; PROPIONIC ACID; TYROSINE;

ACIDEMIA; ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; LIPID PEROXIDATION; LONGITUDINAL STUDY; MALE; MAPLE SYRUP URINE DISEASE; MONITORING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; URINALYSIS;

ADOLESCENT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GLYCINE; HUMANS; ISOPROSTANES; LONGITUDINAL STUDIES; MALE; METABOLISM, INBORN ERRORS; METHYLMALONIC ACID; OXIDATIVE STRESS; PROPIONIC ACIDS; REACTIVE OXYGEN SPECIES; TYROSINE;

ACER;

EID: 67749117788     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.06.007     Document Type: Article

References (67)

1. Han D., et al. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Topology of superoxide production from different sites in the mitochondrial electron transport chain. Biochem. J. 353 (2001) 411-416
2. St-Pierre J., Buckingham J.A., Roebuck S.J., and Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277 (2002) 44784-44790
3. C.R. Scriver, The online metabolic and molecular bases of inherited disease, in: C.R. Scriver (Ed.), vol. 2006, eighth ed., McGraw-Hill Professional, 2006.
4. Das A.M. Regulation of the mitochondrial ATP-synthase in health and disease. Mol. Genet. Metab. 79 (2003) 71-82
5. Ali M.A., Konishi T., and Enhancement of hydroxyl radical generation in the Fenton reaction by alpha-hydroxy acid. Biochem. Mol. Biol. Int. 46 (1998) 137-145
6. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 (2001) 685-716
7. Brusque A.M., et al. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem. Int. 40 (2002) 593-601
8. Sgaravatti A.M., et al. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim. Biophys. Acta 1639 (2003) 232-238
9. Silva A.R., et al. Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid. Metab. Brain Dis. 14 (1999) 157-164
10. Silva C.G., et al. Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab. Brain Dis. 15 (2000) 123-131
11. Ullrich K., et al. Glutaric aciduria type I: pathomechanisms of neurodegeneration. J. Inherit. Metab. Dis. 22 (1999) 392-403
12. Wajner M., and Coelho J.C. Neurological dysfunction in methylmalonic acidemia is probably related to the inhibitory effect of methylmalonate on brain energy production. J. Inherit. Metab. Dis. 20 (1997) 761-768
13. Fighera M.R., et al. Ascorbic acid and alpha-tocopherol attenuate methylmalonic acid-induced convulsions. Neuroreport 10 (1999) 2039-2043
14. Fighera M.R., et al. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int. J. Biochem. Cell Biol. 35 (2003) 465-473
15. Fontella F.U., et al. Propionic and l-methylmalonic acids induce oxidative stress in brain of young rats. Neuroreport 11 (2000) 541-544
16. Latini A., et al. 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res. 956 (2002) 367-373
17. de Oliveira Marques F., et al. Glutaric acid induces oxidative stress in brain of young rats. Brain Res. 964 (2003) 153-158
18. Pettenuzzo L.F., et al. Ascorbic acid prevents water maze behavioral deficits caused by early postnatal methylmalonic acid administration in the rat. Brain Res. 976 (2003) 234-242
19. Montuschi P., Barnes P.J., and Roberts L.J. 2nd. Isoprostanes: markers and mediators of oxidative stress. Faseb J. 18 (2004) 1791-1800
20. Bird S., Miller N.J., Collins J.E., and Rice-Evans C.A. Plasma antioxidant capacity in two cases of tyrosinaemia type 1: one case treated with NTBC. J. Inherit. Metab. Dis. 18 (1995) 123-126
21. Ercal N., Aykin-Burns N., Gurer-Orhan H., and McDonald J.D. Oxidative stress in a phenylketonuria animal model. Free Radic. Biol. Med. 32 (2002) 906-911
22. Kienzle Hagen M.E., et al. Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim. Biophys. Acta 1586 (2002) 344-352
23. Streck E.L., et al. Inhibition of rat brain Na+, K+-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Neurochem. Res. 26 (2001) 1195-1200
24. Streck E.L., et al. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab. Brain Dis. 18 (2003) 147-154
25. Wyse A.T., et al. Nitric oxide synthase inhibition by L-NAME prevents the decrease of Na+, K+-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem. Res. 26 (2001) 515-520
26. Wyse A.T., et al. Inhibition of Na(+), K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27 (2002) 1685-1689
27. Barschak A.G., et al. Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab. Brain Dis. 23 (2008) 71-80
28. Barschak A.G., et al. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab. Brain Dis. 21 (2006) 279-286
29. Bridi R., et al. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int. J. Dev. Neurosci. 21 (2003) 327-332
30. Bridi R., et al. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab. Brain Dis. 20 (2005) 155-167
31. Barschak A.G., et al. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. Metab. Brain Dis. 21 (2006) 11-19
32. Beretta S., et al. Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON). Neurobiol. Dis. 24 (2006) 308-317
33. Latini A., et al. 3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience 135 (2005) 111-120
34. Okun J.G., et al. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J. Biol. Chem. 277 (2002) 14674-14680
35. Pettenuzzo L.F., et al. Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues. Int. J. Dev. Neurosci. 24 (2006) 45-52
36. Reis de Assis D., et al. Inhibition of energy metabolism in cerebral cortex of young rats by the medium-chain fatty acids accumulating in MCAD deficiency. Brain Res. 1030 (2004) 141-151
37. Ribeiro C.A., et al. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem. Res. 33 (2008) 114-124
38. Kirschbaum B. Correlative studies of urine fluorescence and free radical indicators. Clin. Nephrol. 58 (2002) 344-349
39. Wajner M., Latini A., Wyse A.T., and Dutra-Filho C.S. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. 27 (2004) 427-448
40. Kadiiska M.B., et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic. Biol. Med. 38 (2005) 698-710
41. Nourooz-Zadeh J. Key issues in F2-isoprostane analysis. Biochem. Soc. Trans. 36 (2008) 1060-1065
42. Comporti M., et al. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic. Biol. Med. 37 (2004) 724-732
43. Dotan Y., Lichtenberg D., and Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog. Lipid Res. 43 (2004) 200-227
44. Sies H., and Cadenas E. Oxidative stress: damage to intact cells and organs. Philos. Trans. R Soc. Lond. B Biol. Sci. 311 (1985) 617-631
45. Bridi R., et al. Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats. Free Radic. Res. 39 (2005) 71-79
46. Funchal C., et al. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Neurochem. Int. 49 (2006) 640-650
47. Pettenuzzo L.F., et al. Ascorbic acid prevents cognitive deficits caused by chronic administration of propionic acid to rats in the water maze. Pharmacol. Biochem. Behav. 73 (2002) 623-629
48. Rigo F.K., et al. Propionic acid induces convulsions and protein carbonylation in rats. Neurosci. Lett. 408 (2006) 151-154
49. Schwab M.A., et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem. J. 398 (2006) 107-112
50. Cagnon L., and Braissant O. Hyperammonemia-induced toxicity for the developing central nervous system. Brain Res. Rev. 56 (2007) 183-197
51. Garcia M.V., Lopez-Mediavilla C., Juanes de la Pena M.C., and Medina J.M. Antioxidant defence of the neonatal rat brain against acute hyperammonemia. Brain Res. 1001 (2004) 159-163
52. Prestes C.C., et al. Citrulline and ammonia accumulating in citrullinemia reduces antioxidant capacity of rat brain in vitro. Metab. Brain Dis. 21 (2006) 63-74
53. Singh S., Koiri R.K., and Trigun S.K. Acute and chronic hyperammonemia modulate antioxidant enzymes differently in cerebral cortex and cerebellum. Neurochem. Res. 33 (2008) 103-113
54. Widmer R., Kaiser B., Engels M., Jung T., and Grune T. Hyperammonemia causes protein oxidation and enhanced proteasomal activity in response to mitochondria-mediated oxidative stress in rat primary astrocytes. Arch. Biochem. Biophys. 464 (2007) 1-11
55. Andersson H.C., Marble M., and Shapira E. Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet. Med. 1 (1999) 146-150
56. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004) 205-214
57. Siu A.W., Maldonado M., Sanchez-Hidalgo M., Tan D.X., and Reiter R.J. Protective effects of melatonin in experimental free radical-related ocular diseases. J. Pineal. Res. 40 (2006) 101-109
58. Artuch R., et al. A longitudinal study of antioxidant status in phenylketonuric patients. Clin. Biochem. 37 (2004) 198-203
59. Colome C., et al. Lipophilic antioxidants in patients with phenylketonuria. Am. J. Clin. Nutr. 77 (2003) 185-188
60. Delwing D., et al. Alpha-tocopherol and ascorbic acid administration prevents the impairment of brain energy metabolism of hyperargininemic rats. Cell Mol. Neurobiol. 26 (2006) 177-189
61. Kosenko E., et al. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic. Res. 27 (1997) 637-644
62. Martinez-Cruz F., et al. Oxidative stress induced by phenylketonuria in the rat: prevention by melatonin, vitamin E, and vitamin C. J. Neurosci. Res. 69 (2002) 550-558
63. Moyano D., et al. Tocopherol in inborn errors of intermediary metabolism. Clin. Chim. Acta 263 (1997) 147-155
64. Sierra C., et al. Antioxidant status in hyperphenylalaninemia. Clin. Chim. Acta 276 (1998) 1-9
65. Chinnery P., Majamaa K., Turnbull D., and Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. (2006) CD004426
66. Langlois C., et al. Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monothylester and vitamin C treatment. Mol. Genet. Metab. 93 (2008) 306-313
67. Szeto H.H. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J. 8 (2006) E521-E531